| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 02/16/2005 | EP1506180A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582149A Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels |
| 02/16/2005 | CN1580056A Heterocyclic derivatives their preparing methods and uses |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/10/2005 | WO2005012297A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012296A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | WO2005012273A2 Process for the preparation of substituted thiazoles |
| 02/10/2005 | WO2005012249A2 Adamantyglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/10/2005 | WO2005012231A1 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 02/10/2005 | WO2005011812A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibithors |
| 02/10/2005 | WO2005011685A1 Aryl dicarboxamides |
| 02/10/2005 | WO2004112701A3 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/10/2005 | WO2004110983A3 New benzamides as pparϒ modulators |
| 02/10/2005 | WO2004103976A3 Method for synthesising heterocyclic compounds from thiourea derivatives |
| 02/10/2005 | US20050033059 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/10/2005 | US20050033057 Thiazoline acid derivatives |
| 02/10/2005 | US20050033005 Sulfonamide anions as catalysts for NCO oligomerization |
| 02/10/2005 | US20050032865 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 02/10/2005 | US20050032864 Azolidinedione derivatives such as 5-[4-[[3-methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenylmethyl]thiazolidine-2,4-dione potassium salt; dyslipidaemia; eating, cardiovascular and kidney disorders; atherosclerosis, obesity, psoriasis, polycystic ovarian syndrome; hypotensive agents |
| 02/10/2005 | US20050032858 Novel heterocyclic compound and anti-inflamatory agent |
| 02/10/2005 | US20050032856 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 02/10/2005 | US20050032824 E. g., 1-Cyano-3-(2-mercaptobenzothiazol-6-yl)-2-phenylisourea; metabolic diseases; management of the glucose/fatty acid pathway; antilipemic agents; cardiovascular diseases; antidiabetic agents; anticarcinogenic agents; obesity; more profound effects in metabolism shift than ranolazine or trimetazidine |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032788 treating fibrotic lung diseases and fibrotic hypertrophy or fibrosis of prostate, liver, the pleura, pancreas or bowel wall with saturated and unsaturated azoles and salts, e.g., 3-[2-phenyl-2-oxoethyl]-4,5-dimethyl-thiazolium salt |
| 02/10/2005 | US20050032787 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 02/10/2005 | US20050029705 Extrusion die |
| 02/10/2005 | CA2534212A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 02/10/2005 | CA2533658A1 Process for the preparation of substituted thiazoles |
| 02/10/2005 | CA2529662A1 Aryl dicarboxamides |
| 02/09/2005 | EP1504759A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503756A1 Epothilone derivative for the treatment of hepatoma and other cancer diseases |
| 02/09/2005 | EP1436252A4 Hydroxyfattysulfonic acid analogs |
| 02/09/2005 | EP1087951B1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 02/09/2005 | EP0900210B1 Antivirally active heterocyclic azahexane derivatives |
| 02/09/2005 | CN1578910A Neurofibrillary labels |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1188403C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/08/2005 | US6852856 Dissolving a 4-(4,6-dialkyl-aryloxy-s-triazin-2-yl)-), 4-methylmorpholinium halide in water and freezing; or, decreasing the content of a 4,6-dialkyl-s-triazine impurity; condensation agents for amidation and esterification reactions |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852720 Thiazol-2-yl-imine compounds as PDE-7 inhibitors |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | US6852548 Produce light energy when decomposed; stable at room temperature |
| 02/03/2005 | WO2005010028A1 Alpha-amino acid benzothiazolylthio ester as intermediates for manufacture of ace inhibitors and process for preparation thereof |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009437A1 Design and synthesis of optimized ligands for ppar |
| 02/03/2005 | WO2004100881A3 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 02/03/2005 | US20050027128 Substituted thiazoles |
| 02/03/2005 | US20050027125 Intensifiers of adenosine receptors for cardiac arrhythmia |
| 02/03/2005 | US20050026974 Immunogenic conjugates of nitroaromatic compounds and proteins; monoclonal antibodies specific for nitroaromatic compounds , their protein conjugates |
| 02/03/2005 | US20050026973 New heterocyclic oxime compounds |
| 02/03/2005 | US20050026966 Coupling a benzylcarbamate compound containing carboxylic group with an amine to form amide, deprotecting the amide to form free amine, reducing free amine, forming an amine salt with toulene sulfonic acid, coupling bis-toulenesulfonic acid salt with a thiazole derivative to form the end product |
| 02/03/2005 | US20050026945 Cyanoamide compounds useful as malonyl-CoA decarboxylase inhibitors |
| 02/03/2005 | US20050026943 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026907 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 02/03/2005 | US20050026906 Such as N-4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-methyl-isonicotinamide; for control or prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026785 Novel phenyl-propargylether derivatives |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/03/2005 | CA2533417A1 Design and synthesis of optimized ligands for ppar |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502590A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes |
| 02/02/2005 | EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres |
| 02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/02/2005 | EP1501812A1 Pna monomer and precursor |
| 02/02/2005 | EP1501811A1 Process for preparing thiazole derivative and the intermediate compounds for preparing the same |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501794A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors |
| 02/02/2005 | EP1501509A2 Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
| 02/02/2005 | EP1501508A1 Inhibitors of histone deacetylase |
| 02/02/2005 | EP1181283B1 Diaminothiazoles and their use for inhibiting protein kinases |
| 02/02/2005 | CN1575287A Alpha-form or beta-form crystal of acetanilide derivative |
| 02/02/2005 | CN1575286A Thiophene-amd thiazolesulfonamides as antineoplastic agents |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575280A Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575171A Novel anti-diabetic agents |
| 02/01/2005 | US6849742 Binaphthol derivative and process for producing the same |
| 02/01/2005 | US6849741 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin |
| 02/01/2005 | US6849651 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/01/2005 | US6849632 Heteroaryl alkyl piperazine derivatives |
| 02/01/2005 | US6849097 I.e., N-(thiophen-2 or-3-ylmethyl)-, N-(furan-3-ylmethyl)-, N-(1H-imidazol-2-ylmethyl)- and N-(pyrrol-2-ylmethyl)-p-phenylenediamines; developers for hair dyes |
| 01/27/2005 | WO2005007798A2 Hydroxypropyl methacrylamide polymers and copolymers comprising reactive thiazoline-2-thione |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |